The role of polycyclic aromatic hydrocarbon metabolism in dimethylbenz[a]anthracene-induced pre-B lymphocyte apoptosis

Toxicology and Applied Pharmacology

Volumn 161, Issue 1, 1999, Pages 10-22

  Mann, K K ^a   Matulka, R A ^a   Hahn, M E ^b   Trombino, A F ^a   Lawrence, B P ^c   Kerkvliet, N I ^d   Sherr, D H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WOODS HOLE OCEANOGRAPHIC INSTITUTION   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA NAPHTHOFLAVONE; AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CYTOCHROME P450; DIMETHYLBENZ[A]ANTHRACENE; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOTOXICITY; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; SIGNAL TRANSDUCTION; XENOBIOTIC METABOLISM;

ANIMALIA;

EID: 0033570919     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8778     Document Type: Article

References (80)

1. Ashton-Rickardt P., Tonegawa S. A differential-avidity model for T-cell selection. Immunol. Today. 15:1994;362-366.
2. Bigelow S., Nebert D. The Ah regulatory gene product. Survey of nineteen polycyclic aromatic compounds' and fifteen benzo[a]pyrene metabolites' capacity to bind to the cytosolic receptor. Toxicol. Lett. 10:1982;109-118.
3. Blank J., Tucker A., Sweatlock J., Gasiewicz T., Luster M. Alpha-napthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression. Mol. Pharmacol. 32:1987;168-172.
4. Boobis A., Atlas S., Nebert D. Carcinogenic benzo(a)pyrene metabolites bound to DNA: Metabolic formation by human cultured lymphocytes and by human liver microsomes. Pharmacology. 17:1978;241-248.
5. Budd R., Mixter P. The origin of CD4-CD8-TCR alpha beta+ thymocytes: A model based on T-cell receptor avidity. Immunol. Today. 16:1995;428-431.
6. Burchiel S., Davis D., Gomez M., Montano R., Barton S., Seamer L. Inhibition of lymphocyte activation in splenic and gut-associated lymphoid tissues following oral exposure of mice to 7,12-dimethylbenz[a]anthracene. Toxicol. Appl. Pharmacol. 105:1990;434-442.
7. Burchiel S., Davis D., Ray S., Barton S. DMBA induces programmed cell death (apoptosis) in the A20.1 murine B cell lymphoma. Fundam. Appl. Toxicol. 21:1993;120-124.
8. Burchiel S., Hadley W., Barton S., Fincher R., Lauder L., Dean J. Persistent suppression of humoral immunity produced by 7,12-dimethylbenz[a]anthracene (DMBA) in B6C3F1 mice: Correlation with changes in spleen cell surface markers detected by flow cytometry. Int. J. Immunopharmacol. 10:1988;369-376.
9. Carrier F., Chang C., Duh J., Nebert D., Puga A. Interaction of the regulatory domains of the murine CyP1a1 gene with two DNA-binding proteins in addition to the Ah receptor and the Ah receptor nuclear translocator (ARNT). Biochem. Pharmacol. 48:1994;1767-1778.
10. Carver L., Bradfield C. Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J. Biol. Chem. 272:1997;11452-11456.
11. Chang C.-Y., Smith D., Prasad V., Sidman C., Nebert D., Puga A. Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. Pharmacogenetics. 3:1993;312-321.
12. Chen H.-S., Perdew G. Subunit composition of the heteromeric cytosolic aryl hydrocarbon receptor complex. J. Biol. Chem. 269:1994;27554-27558.
13. Coombs D., Watts N. Generating sucrose gradients in three minutes by tilted tube rotation. Anal. Biochem. 148:1985;254-259.
14. Davila D., Romero D., Burchiel S. Human T cells are highly sensitive to suppression of mitogenesis by polycyclic aromatic hydrocarbons and this effect is differentially reversed by alpha-napthoflavone. Toxicol. Appl. Pharmacol. 139:1996;233-241.
15. Dean J., Luster M., Boorman G., Lauer L., Leubke R., Lawson L. Selective immunosuppression resulting from exposure to the carcinogenic congener of benzopyrene in B6C3F1 mice. Clin. Exp. Immunol. 52:1983;199-206.
16. Dolwick K., Swanson H., Bradfield C. In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition. Proc. Natl. Acad. Sci. USA. 90:1993;8566-8570.
17. Ema M., Sogawa K., Watanabe N., Chujoh Y., Matsushita N., Gotoh O., Funae Y., Fujii-Kuriyama Y. cDNA cloning and structure of mouse putative Ah receptor. Biochem. Biophys. Res. Commun. 184:1992;246-253.
18. Ge N.-L., Elferink C. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. J. Biol. Chem. 273:1998;22708-22713.
19. Gonzalez F., McKenzie P., Kimura S., Nebert D. Isolation and characterization of full-length mouse cDNA and genomic clones of 3-methylcholanthrene-inducible cytochrome P-1-450 and P-3-450. Gene. 29:1984;281-292.
20. Hahn M. Cytochrome P4501A induction and inhibition by 3,3′,4,4′-tetrachlorobiphenyl in an Ah-receptor-containing fish hepatoma cell line (PLHC-1). Aquat. Toxicol. 26:1993;185-208.
21. Hahn M., Poland A., Glover E., Stegeman J. Photoaffinity labeling of the Ah receptor: Phylogenetic survey of diverse vertebrate and invertebrate species. Arch Biochem. Biophys. 310:1994;218-228.
22. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35:1995;307-340.
23. Harper N., Steinberg M., Thomsen J., Safe S. Halogenated aromatic hydrocarbon-induced suppression of the plaque-forming cell response in B6C3F1 splenocytes cultured with allogeneic mouse serum: Ah receptor structure activity relationships. Toxicology. 99:1995;199-206.
24. Heidel S., Czuprynski C., Jefcoate C. Bone marrow stromal cells constitutively express high levels of cytochrome P4501B1 that metabolize 7,12-dimethylbenzanthracene. Mol. Pharmacol. 54:1998;1000-1006.
25. Hinoshita F., Hardin J., Sherr D. H. Fluoranthene induces programmed cell death and alters growth of immature B cell populations in bone marrow cultures. Toxicology. 73:1992;203-218.
26. Holladay S., Smith B. Alterations in murine fetal thymus and liver hematopoietic cell populations following developmental exposure to 7,12-dimethylbenz[a]anthracene. Environ. Res. 68:1995;106-113.
27. House R., Lauer L., Murray M., Dean J. Suppression of T-helper cell function in mice following exposure to the carcinogen 7,12-dimethylbenzanthracene and its restoration by interleukin-2. Int. J. Immunopharmacol. 9:1987;89-97.
28. House R., Pallardy M., Dean J. Suppression of murine cytotoxic T-lymphocyte induction following exposure to 7,12-dimethylbenzanthracene: Dysfunction of antigen recognition. Int. J. Immunopharmacol. 11:1989;207-215.
29. Hushka D., Hushka L., Williams J., Greenlee W. Aryl hydrocarbon receptor-dependent control of Rb phosphorylation and G1/S progression in rat hepatoma cells. Proc. Am. Assoc. Cancer Res. 39:1998;252.
30. Kafafi S., Afeefy H., Ali A., Said H., Kafafi A. Binding of polychlorinated biphenyls to the aryl hydrocarbon receptor. Environ. Health Perspect. 101:1993;422-428.
31. Kamps C., Safe S. Binding of polynuclear aromatic hydrocarbons to the rat 4S cytosolic binding protein: Structure-activity relationships. Cancer Lett. 34:1987;129-137.
32. Kawabata T., White K. Suppression of the in vitro humoral immune response of murine splenocytes by benzo[a]pyrene metabolites and inhibition of benzo[a]pyrene-induced immunosuppression by alpha-napthoflavone. Cancer Res. 47:1987;2317-2322.
33. Kerkvliet N., Steppan L., Brauner J., Deyo J., Henderson M., Tomar R. Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Evidence for Ah receptor-dependent and Ah receptor-independent mechanisms of immunosuppression. Toxicol. Appl. Pharmacol. 105:1990;26-36.
34. Koga N., Beppu M., Yoshimura H. Metabolism in vivo of 3,4,5,3′,4′-pentachlorobiphenyl and toxicological assessment of the metabolite in rats. J. Pharmacobio-Dyn. 13:1990.
35. Kouri R., McKinney C., Slomiany D., Snodgrass D., Wray N., McLemore T. Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res. 42:1982;5030-5037.
36. Kress S., Greenlee W. Cell-specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Res. 57:1997;1264-1269.
37. Ladics G., Kawabata T., White K. L. Jr. Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and inhibition of immunosuppression by alpha-napthoflavone. Toxicol. Appl. Pharmacol. 110:1991;31-44.
38. Ladics G., Kawabata T., Munson A., White K. L. Jr. Metabolism of benzo(a)pyrene by murine splenic cell types. Toxicol. Appl. Pharmacol. 116:1992;248-257.
39. Lee M., Kirlin W., Sturrup M., Rodriguez J., Urso P. Variation in the response of T cells to concanavalin A after in vitro exposure to benzo[a]pyrene and 2-aminofluorene. Immunopharmacol. Immunotoxicol. 18:1996;309-321.
40. Lummus Z., Henningsen G. Modulation of T-cell ontogeny by transplacental benzo(a)pyrene. Int. J. Immunpharmacol. 17:1995;339-350.
41. Luster M., Germolec D., Clark G., Weigand G., Rosenthal G. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation. J. Immunol. 140:1988;928-935.
42. Lyte M., Bick P. Modulation of interleukin-1 production by macrophages following benzo(a)pyrene exposure. Int. J. Immunopharmacol. 8:1986;377-381.
43. Ma Q., Whitlock J. P. Jr. A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 272:1997;8878-8884.
44. Morris D., Jeong H., Stevens W., Chun Y., Karras J., Holsapple M. Serum modulation of the effects of TCDD on the in vitro antibody response and on enzyme induction in primary hepatocytes. Immunopharmacology. 27:1994;93-105.
45. Mounho B., Davila D., Burchiel S. Characterization of intracellular calcium responses produced by polycyclic aromatic hydrocarbons in surface marker-defined human peripheral blood mononuclear cells. Toxicol. Appl. Pharmacol. 145:1997;323-330.
46. Myers M., Blanton R., Bick P. Inhibition of IL-2 responsiveness following exposure to benzo(a)pyrene is due to alterations in accessory cell function. Int. J. Immunopharmacol. 10:1988;177-186.
47. Near R., Matulka R., Mann K., Gogate S., Trombino A., Sherr D. Regulation of pre-B cell apoptosis by aryl hydrocarbon receptor/transcription factor-expressing stromal/adherent cells. Proc. Soc. Exp. Biol. Med. 221:1999;242-252.
48. Nebert D. Proposed role of drug-metabolizing enzymes: Regulation of steady state levels of the ligand that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol. Endocrinol. 5:1991;1203-1214.
49. Noelle R., Shepherd D., Fell H. Cognate interaction between T helper cells and B cells. VII. Role of contact and lymphokines in the expression of germ-line and mature gamma 1 transcripts. J. Immunol. 149:1992;1164-1169.
50. Ortiz de Montellano P., Correia M. Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. Annu. Rev. Pharmacol. Toxicol. 23:1983;481-503.
51. Pietrangeli C., Hayashi S.-I., Kincade P. Stromal cell lines which support lymphocyte growth: Characterization, sensitivity to radiation and responsiveness to growth factor. Eur. J. Immunol. 18:1988;863-872.
52. Piskorska-Pliszczynska J., Keys B., Safe S., Newman M. The cytosolic receptor binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons. Toxicol. Lett. 34:1986;67-74.
53. Poland A., Glover E. Genetic expression of aryl hydrocarbon hydroxylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin: Evidence for a receptor mutation in genetially non-responsive mice. Mol. Pharmacol. 11:1975;389-398.
54. Poland A., Glover E., Kende A. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. J. Biol. Chem. 251:1976;4936-4946.
55. Probst M., Fan C., Tessier-Lavigne M., Hankinson O. Two murine homologs of the Drosophila single-minded protein that interact with the mouse aryl hydrocarbon receptor nuclear translocator proteins. J. Biol. Chem. 14:1997;4451-4457.
56. Quadri, S, Qadri, A, Mann, K, and, Sherr, D. 1999, Galangin, a naturally occuring bioflavonoid, inhibits aryl hydrocarbon receptor activity and blocks polycyclic aromatic hydrocarbon-induced preB cell apoptosis. (in preparation).
57. Rigdon R., Neal J. Relationship of leukemia to lung and stomach tumors in mice fed benzo[a]pyrene. Proc. Soc. Exp. Biol. 130:1969;146-148.
58. Safe S., Krishnan V. Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. Arch. Toxicol. 17:1995;99-115.
59. Savas U., Bhattacharyya K., Christou M., Alexander D., Jefcoate C. Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. J. Biol. Chem. 269:1994;14905-14911.
60. Savas U., Christou M., Jefcoate C. Mouse endometrium stromal cells express a polycyclic aromatic hydrocarbon-inducible cytochrome P450 that closely resembles the novel P450 in mouse embryo fibroblasts (P450EF). Carcinogenesis. 14:1993;2013-2018.
61. Schmidt J., Bradfield C. Ah receptor signaling pathways. Annu. Rev. Cell. Dev. Biol. 12:1996;55-89.
62. Schmidt J., Su G. H-T., Reddy J., Simon M., Bradfield C. Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. USA. 93:1996;6731-6736.
63. Shimada T., Hayes C., Yamazaki H., Amin S., Hecht S., Guengerich F., Sutter T. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56:1996;2979-2984.
64. Spink D., Spink B., Cao J., DePasquale J., Pentecost B., Fasco M., Li Y., Sutter T. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis. 19:1998;291-298.
65. Thirman M., Albrecht J., Krueger M., Erickson R., Cherwitz D., Park S., Gelboin H., Holtzman J. Induction of cytochrome CYP1A1 and formation of toxic metabolites of benzo[a]pyrene by rat aorta: A possible role in atherogenesis. Proc. Natl. Acad. Sci. USA. 91:1994;5397-5401.
66. Thurmond L., House R., Lauer L., Dean J. Suppression of splenic lymphocyte function by 7,12-dimethylbenzanthracene (DMBA) in vitro. Toxicol. Appl. Pharmacol. 93:1988;369-377.
67. Tian Y., Ke S., Denison M. S., Rabson A. B., Gallo M. A. Ah receptor and NF-κB interations, a potential mechanism for dioxin toxicity. J. Biol. Chem. 274:1999;510-515.
68. Tomar R., Lim S., Gill S. The effects of epoxidized xenobiotics on mitogen responsiveness and antibody-producing ability of spleen cells in vitro. Int. J. Immunopharmacol. 13:1991;57-65.
69. Tsui H., Okey A. Rapid vertical tube rotor gradient assay for binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to the Ah receptor. Can. J. Physiol. (Lond.) Pharmacol. 59:1981;927-931.
70. Urso P., Gengozian N., Rossi R., Johnson R. Supression of humoral and cell-mediated immune responses in vitro by benzo[a]pyrene. J. Immunopharmacol. 8:1986;223-241.
71. Urso P., Johnson R. Quantitative and functional change in T cells of primiparous mice following injection of benzo(a)pyrene at the second trimester of pregnancy. Immunopharmacol. Immunotoxicol. 10:1988;195-217.
72. Ward E., Murray M., Lauder L., House R., Dean J. Persistent suppression of humoral and cell mediated immunity in mice following exposure to the polycyclic aromatic hydrocarbon, 7,12-dimethylbenz[a]anthracene. Int. J. Immunopharmacol. 8:1986;13-22.
73. Wen L.-P., Koeiman N., Whitlock J. P. Dioxin-inducible, Ah receptor-dependent transcription in vitro. Annu. Rev. Biochem. 56:1990;945-993.
74. White K., Lysy H., Holsapple M. Immunosuppression by polycyclic aromatic hydrocarbons: A structure-activity relationship in B6C3F1 and DBA/2 mice. Immunopharmacology. 9:1985;155-164.
75. Whitlock C., Robertson D., Witte O. Murine B lymphopoiesis in long-term culture. J. Immunol. Methods. 67:1984;353-369.
76. Wojdani A., Attarzadeh M., Wode-Tsadik G., Alfred L. Immunocytotoxicity effects of polycyclic aromatic hydrocarbons on mouse lymphocytes. Toxicology. 31:1984;181-189.
77. Yamaguchi K., Matulka R., Shneider A., Toselli P., Trombino A., Yang S., Hafer L., Mann K., Tao X., Tilly J., Near R., Sherr D. H. Induction of pre-B cell apoptosis by 7, 12-dimethylbenz[a]anthracene in long-term primary bone marrow cultures. Toxicol. Appl. Pharmacol. 146:1997a;190-203.
78. Yamaguchi K., Near R., Matulka R., Shneider A., Toselli P., Trombino A., Sherr D. H. Activation of the aryl hydrocarbon receptor/transcription factor and bone marrow stromal cell-dependent pre-B cell apoptosis. J. Immunol. 158:1997b;2165-2173.
79. Yamaguchi K., Near R., Shneider A., Cui H., Ju S.-T., Sherr D. H. Fluoranthene-induced apoptosis in murine T cell hybridomas is independent of the aromatic hydrocarbon receptor. Toxicol. Appl. Pharmacol. 139:1996;144-152.
80. Yoshimura H., Yonemoto Y., Yamada H., Koga N., Oguri K., Saeki S. Metabolism in vivo of 3,4,3′,4′-tetrachlorobiphenyl and toxicological assessment of the metabolites in rats. Xenobiotica. 17:1987;897-910.